“We are very pleased to welcome Anna to AcuCort. Her solid experience in business development, international partnerships and commercialisation within life science will be an important addition to our growth journey. Anna’s drive, structured approach and strategic ability make her an excellent fit for our team,” says Jonas Jönmark, CEO of AcuCort.

Anna Chérouvrier Hansson

At SenzaGen, she played a key role in building and driving the company’s business development and commercialization strategy, establishing a global network of licensees and distributors, and negotiating international agreements. At Camurus, she was instrumental in the launch of the company’s first commercial product in supportive cancer care across several international markets.

“I am very much looking forward to joining AcuCort and contributing to the company’s continued growth and commercial success,” says Anna Chérouvrier Hansson, incoming Business Development Director.